Revised SPC: Stelara (ustekinumab) pre-filled syringes
SPC highlights a licence extension for use in moderate to severe plaque psoriasis in children and adolescent patients from the age of 6 years and older, who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.
Source:
electronic Medicines compendium